Alarm as severe reactions to Ozempic set to SOAR by 350 per cent, new data reveals
Bad reactions to popular weight-loss drugs, including Ozempic and Wegovy, are on track to soar by more than 350 per cent within a year, new data has suggested.
Wegovy
since
auto-detected in 483 stories
14 hours ago
2 days ago
Novo Nordisk cuts 2025 guidance as drug copycats hit Wegovy sales, posts first-quarter profit beat
Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.
7 days ago
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Starting July 1, Caremark will prioritize Wegovy on its formulary, making the weekly injection more accessible to its members.
8 days ago
Seventy Americans are being hospitalized per DAY due to Ozempic as doctors issue urgent warning
Weight-loss drugs like Ozempic and Wegovy are sending dozens of Americans to the hospital every day with potentially life-threatening side effects.
10 days ago
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 18%
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 18%
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 18%
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.